Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

ELECTIVE CONVERSION TO SIROLIMUS VS. CONTINUED TACROLIMUS IN KIDNEY TRANSPLANTATION (THE 3C STUDY): RESULTS OF A RANDOMIZED TRIAL

Journal article

Haynes R. et al, (2018), American Journal of Transplantation, 30, 63 - 64

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.

Journal article

Parish S. et al, (2018), Circ Genom Precis Med, 11

The Role of Lipoprotein(a) in Chronic Kidney Disease.

Journal article

Hopewell JC. et al, (2018), Journal of lipid research

Impact of chronic kidney disease on household income

Journal article

Morton RL. et al, (2017), Kidney International Reports

Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.

Journal article

Patrono C. et al, (2017), J Am Coll Cardiol, 70, 1760 - 1776

PCSK9 inhibition: a new player in cholesterol-lowering therapies?

Journal article

Preiss D. and Baigent C., (2017), Nature Reviews Nephrology

Safety and efficacy of statins reply

Journal article

Collins R. et al, (2017), LANCET, 389, 1099 - 1100

Are statins useful in patients with advanced chronic kidney disease? - Authors' reply.

Journal article

Herrington WG. et al, (2016), Lancet Diabetes Endocrinol, 4, 971 - 972

Interpretation of the evidence for the efficacy and safety of statin therapy.

Journal article

Collins R. et al, (2016), Lancet (London, England)

Diabetes and Cause-Specific Mortality in Mexico City.

Journal article

Alegre-Díaz J. et al, (2016), N Engl J Med, 375, 1961 - 1971

Lessons from the controversy over statins - Authors' reply.

Journal article

Armitage J. et al, (2016), Lancet, 388, 2237 - 2238

Cholesterol and Lipids

Chapter

Clarke R. and Baigent C., (2016), International Encyclopedia of Public Health, 9 - 21

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).

Journal article

Staplin N. et al, (2016), American Journal of Kidney Diseases, 68, 371 - 380

Load More +